Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
Pfizer and Beam Therapeutics announce research collaboration
Pfizer announced a four-year exclusive research collaboration with Beam Therapeutics focused on in vivo base-editing programs for rare genetic diseases. The reported terms include an upfront payment to Beam and potential milestone payments.
2021
Beam Therapeutics acquires Guide Therapeutics
Beam Therapeutics announced that it had acquired Guide Therapeutics, a Georgia-based biotech startup developing gene-therapy delivery methods, for $120 million in stock upfront plus potential milestone payments.
2019
Beam Therapeutics appoints Graham Cooper to its board
Beam Therapeutics announced the appointment of Graham Cooper to its board of directors.
2019
Beam Therapeutics appoints Brian Riley as SVP of Technical Operations
Beam Therapeutics announced the appointment of Brian Riley as Senior Vice President of Technical Operations.